On Invalid Date, Idexx Laboratories (NASDAQ: IDXX) reported Q2 2023 earnings per share (EPS) of $2.70, up 71.97% year over year. Total Idexx Laboratories earnings for the quarter were $224.24 million. In the same quarter last year, Idexx Laboratories's earnings per share (EPS) was $1.57.
As of Q3 2023, Idexx Laboratories's earnings has grown 21.4% year over year. This is 25.28 percentage points higher than the US Diagnostics & Research industry earnings growth rate of -3.88%. Idexx Laboratories's earnings in the past year totalled $791.44 million.
What is IDXX's earnings date?
Idexx Laboratories's earnings date is Invalid Date. Add IDXX to your watchlist to be reminded of IDXX's next earnings announcement.
What was IDXX's revenue last quarter?
On Invalid Date, Idexx Laboratories (NASDAQ: IDXX) reported Q2 2023 revenue of $943.63 million up 9.65% year over year. In the same quarter last year, Idexx Laboratories's revenue was $860.55 million.
What was IDXX's revenue growth in the past year?
As of Q3 2023, Idexx Laboratories's revenue has grown 6.21% year over year. This is 4.32 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 1.89%. Idexx Laboratories's revenue in the past year totalled $3.51 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.